Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Depreciation and Depletion (2019 - 2025)

Volitionrx (VNRX) has disclosed Depreciation and Depletion for 7 consecutive years, with $242093.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation and Depletion fell 10.57% year-over-year to $242093.0, compared with a TTM value of $1.0 million through Sep 2025, down 9.29%, and an annual FY2024 reading of $1.1 million, changed 0.0% over the prior year.
  • Depreciation and Depletion was $242093.0 for Q3 2025 at Volitionrx, down from $246677.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $307768.0 in Q4 2023 and bottomed at $173018.0 in Q4 2021.
  • Average Depreciation and Depletion over 5 years is $242757.3, with a median of $246248.0 recorded in 2025.
  • The sharpest move saw Depreciation and Depletion surged 49.54% in 2021, then decreased 11.26% in 2025.
  • Year by year, Depreciation and Depletion stood at $173018.0 in 2021, then skyrocketed by 38.96% to $240432.0 in 2022, then grew by 28.01% to $307768.0 in 2023, then decreased by 7.67% to $284176.0 in 2024, then fell by 14.81% to $242093.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for VNRX at $242093.0 in Q3 2025, $246677.0 in Q2 2025, and $246248.0 in Q1 2025.